How should I treat infective endocarditis in an adult patient, including empiric therapy, pathogen‑specific antibiotics, dosing, duration, and adjustments for native versus prosthetic valves and impaired renal function?

Treatment of Infective Endocarditis

Immediate Diagnostic Actions Before Starting Antibiotics

Obtain three separate sets of blood cultures at 30-minute intervals from distinct venipuncture sites before initiating any antimicrobial therapy. 1 This is the single most critical step to maximize pathogen recovery and guide definitive therapy. 2

Empirical Antibiotic Regimens

Community-Acquired Native Valve Endocarditis

Start ampicillin 12 g/day IV (divided into 4–6 doses) + (flu)cloxacillin or oxacillin 12 g/day IV (divided into 4–6 doses) + gentamicin 3 mg/kg/day IV or IM once daily. 2, 3 This triple-drug regimen provides comprehensive coverage for the three most common pathogens: staphylococci, streptococci, and enterococci. 1

• For penicillin-allergic patients: Replace the β-lactam components with vancomycin 30 mg/kg/day IV (divided into 2 doses) while continuing gentamicin. 2, 3

Healthcare-Associated or Nosocomial Native Valve Endocarditis

Initiate vancomycin 30 mg/kg/day IV (divided into 2 doses) + gentamicin 3 mg/kg/day IV or IM once daily. 2, 3 This regimen targets methicillin-resistant Staphylococcus aureus (MRSA), which exceeds 5% prevalence in healthcare settings. 1

Early Prosthetic Valve Endocarditis (< 12 months post-surgery)

Use vancomycin 30 mg/kg/day IV (divided into 2 doses) + gentamicin 3 mg/kg/day IV or IM once daily + rifampin 900–1200 mg/day IV or oral (divided into 2–3 doses) + cefepime 6 g/day IV (divided into 3 doses). 4, 3

• Critical timing: Start rifampin 3–5 days after vancomycin and gentamicin have been initiated. 4, 3
• Rationale: Rifampin provides essential biofilm penetration on prosthetic material, while cefepime covers non-HACEK Gram-negative organisms common in healthcare-associated infections. 1, 4

Late Prosthetic Valve Endocarditis (≥ 12 months post-surgery)

Treat as native valve endocarditis with ampicillin 12 g/day IV + (flu)cloxacillin/oxacillin 12 g/day IV + gentamicin 3 mg/kg/day IV or IM once daily. 4, 3 Late prosthetic valve endocarditis has a microbiologic profile resembling native valve disease, with staphylococci, viridans-group streptococci, and enterococci predominating. 4

Pathogen-Specific Definitive Therapy

Methicillin-Susceptible Staphylococcus aureus (MSSA) Native Valve

Switch to (flu)cloxacillin or oxacillin 12 g/day IV (divided into 4–6 doses) for 4–6 weeks without adding gentamicin. 5 Recent data demonstrate no clinical benefit from adding aminoglycosides to MSSA native valve endocarditis, only increased nephrotoxicity. 5

• Alternative: Cefazolin is an acceptable substitute for anti-staphylococcal penicillins. 5

Methicillin-Resistant Staphylococcus aureus (MRSA)

Continue vancomycin 30 mg/kg/day IV (divided into 2 doses) for 6 weeks. 5

• Alternative: Daptomycin is an acceptable option for MRSA. 5
• For prosthetic valves: Add gentamicin for the first 2 weeks and rifampin for the entire 6-week duration. 4, 5

Fully Penicillin-Susceptible Viridans-Group Streptococci (MIC ≤ 0.1 mg/L)

Penicillin G 12–20 million units/day IV (divided into 4–6 doses) for 4 weeks. 1

• Alternative: Ceftriaxone 2 g IV once daily for 4 weeks is equally effective. 1, 2
• For patients ≥ 65 years or with elevated creatinine: Use penicillin G adapted to renal function or ceftriaxone alone without gentamicin. 1

Enterococcal Endocarditis

Ampicillin 12 g/day IV (divided into 4–6 doses) + gentamicin 3 mg/kg/day IV (divided into 2–3 doses) for 4–6 weeks. 1, 2 This synergistic bactericidal combination is essential for effective eradication. 2

• For ampicillin-resistant but gentamicin-susceptible strains: Replace ampicillin with vancomycin 30 mg/kg/day IV. 2
• For multiresistant enterococci (resistant to ampicillin, gentamicin, and vancomycin): Use daptomycin 10 mg/kg/day + high-dose ampicillin 200 mg/kg/day IV for ≥ 8 weeks. 2
• Alternative for multiresistant strains: Linezolid 600 mg IV or oral twice daily for ≥ 8 weeks, with close monitoring for hematologic toxicity. 2

HACEK Group Organisms

Ceftriaxone 2 g/day IV for 4 weeks in native valve endocarditis and 6 weeks in prosthetic valve endocarditis. 1 Some HACEK organisms produce beta-lactamases, making ceftriaxone the first-line option over ampicillin. 1

Non-HACEK Gram-Negative Bacteria

Early surgery plus long-term (at least 6 weeks) therapy with bactericidal combinations of beta-lactams and aminoglycosides. 1 These rare but severe infections require consultation with an infectious disease specialist from the endocarditis team. 1

Fungal Endocarditis

Combination antifungal therapy plus surgical valve replacement is mandatory. 1 Mortality exceeds 50% despite aggressive treatment. 1, 2

Blood Culture-Negative Endocarditis

After Prior Antibiotic Exposure

Ampicillin-sulbactam 12 g/24 h IV (divided into 4 doses) + gentamicin 3 mg/kg/day for 4–6 weeks. 1, 2

Suspected Bartonella Infection (e.g., cat exposure)

Ceftriaxone 2 g/day IV + doxycycline 200 mg/day IV or oral (divided into 2 doses) for 6 weeks, with gentamicin 3 mg/kg/day for the first 2 weeks. 1, 2

Documented Bartonella (culture-positive)

Doxycycline 200 mg/24 h IV or oral (divided into 2 doses) + gentamicin 3 mg/kg/day for 2 weeks, then continue doxycycline alone for a total of 6 weeks. 1

Mandatory consultation with an infectious disease specialist is required for all blood culture-negative endocarditis cases. 1, 2, 3

Treatment Duration

Native Valve Endocarditis

Minimum 4 weeks of therapy measured from the first day blood cultures become negative. 2, 5

• Extended to 6 weeks for: Complicated infections (perivalvular abscess, large vegetations) or specific pathogens such as Streptococcus anginosus group. 2

Prosthetic Valve Endocarditis

Minimum 6 weeks for all cases. 1, 4, 5

Obtain repeat blood cultures every 24–48 hours until clearance is documented. 2

Adjustments for Impaired Renal Function

Gentamicin Monitoring

Check gentamicin trough levels weekly; target trough < 1 µg/mL (ideally < 0.1 mg/L) to avoid renal or ototoxic effects. 1, 3

• For once-daily dosing: Target peak 10–12 mg/L. 3
• Limit gentamicin to maximum 2 weeks to reduce toxicity. 5

Vancomycin Monitoring

Maintain vancomycin trough levels 10–15 µg/mL. 4

Penicillin G Dose Adjustment

Adapt penicillin G dosing to renal function in patients ≥ 65 years or with elevated serum creatinine. 1

Outpatient Parenteral Antibiotic Therapy (OPAT)

Critical Phase (Weeks 0–2)

OPAT has restricted indication during the first 2 weeks; inpatient treatment is preferred. 1, 2

• Consider OPAT only if: Oral streptococci or Streptococcus bovis, native valve, patient stable, no complications. 1, 2

Continuation Phase (Beyond Week 2)

OPAT may be feasible if the patient is medically stable without heart failure, concerning echocardiographic features, neurological signs, or renal impairment. 1, 2

• Program requirements: Daily nursing evaluation and physician assessment 1–2 times per week; physician-directed programs are preferred over home-infusion models. 1, 2

Surgical Indications

Emergency Surgery (Within 24 Hours)

Severe acute regurgitation causing refractory pulmonary edema or cardiogenic shock. 1

Urgent Surgery (Within Days)

• Perivalvular abscess, false aneurysm, fistula formation, heart block, or destructive penetrating lesions. 1, 2
• Vegetations > 10 mm with recurrent embolic events despite appropriate antibiotics. 1, 2
• Fungal endocarditis or infections with highly resistant organisms (e.g., non-HACEK Gram-negatives). 1, 2
• Prosthetic valve endocarditis and Staphylococcus aureus native valve endocarditis are almost always surgical diseases. 1

Early consultation with a cardiac surgeon is recommended to determine the best therapeutic approach. 1

Critical Pitfalls to Avoid

• Never start antibiotics before obtaining blood cultures unless the patient is in septic shock. 2
• Do not add gentamicin to MSSA native valve endocarditis—it provides no benefit and increases nephrotoxicity. 5
• Do not delay surgery when indicated; progressive heart failure and irreversible structural damage can occur rapidly. 1
• Aminoglycoside use has decreased dramatically over the past 20 years; when used, administer once daily and limit to maximum 2 weeks. 5
• For patients on long-term oral anticoagulation who develop endocarditis, discontinue warfarin and replace with heparin immediately after diagnosis. 1
• Rifampin must be started 3–5 days after vancomycin in early prosthetic valve endocarditis, not simultaneously, to avoid antagonism. 4, 3